Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 12, 2023
Cytomegalovirus Immune reconstitution in cord blood transplant recipients on letermovir prophylaxisMaheen Z Abidi, Kyle C Molina, Krystle Garth, et al.
Transplantation Proceedings|August 15, 2024
Cytomegalovirus Retinitis in the Modern Era of Solid Organ TransplantationSias J Scherger, Kyle C Molina, Alan G Palestine, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 7, 2024
Prospective evaluation of single-dose aminoglycosides for treatment of complicated cystitis in the emergency departmentJordan E Jenrette, Kyle Coronato, Matthew A Miller, et al.
Pharmacy (Basel, Switzerland)|April 26, 2024
Evaluation of Oral Amoxicillin/Clavulanate for Urinary Tract Infections Caused by Ceftriaxone Non-Susceptible EnterobacteralesMadison E Salam, Meghan Jeffres, Kyle C Molina, et al.
Surgical Infections|July 24, 2019
Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal ClearanceKyle C Molina, Scott T Hall, Jeffrey F Barletta, et al.
International Journal of Antimicrobial Agents|February 20, 2021
Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of careTanner M Johnson, Kyle C Molina, Matthew A Miller, et al.
Clinical Pharmacokinetics|December 21, 2021
Clinical Pharmacokinetics and Pharmacodynamics of DalbavancinKyle C Molina, Matthew A Miller, Scott W Mueller, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|February 29, 2024
Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosaScott W Mueller, Kyle C Molina, Brittany Blass, et al.
Therapeutic Advances in Infectious Disease|January 22, 2024
Substance use disorder-associated infections' treatment with dalbavancin enabling outpatient transition (SUDDEN OUT) - an investigator-initiated single-arm unblinded prospective cohort studyMartin Krsak, Sias Scherger, Matthew A Miller, et al.
Open Forum Infectious Diseases|July 15, 2021
Effectiveness of Bezlotoxumab for Prevention of Recurrent <i>Clostridioides difficile</i> Infection Among Transplant RecipientsTanner M Johnson, Amanda H Howard, Matthew A Miller, et al.
Pageof 6